Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 5/20 | 0.37 |
| ▸ | MGAT2 | Q10469 | 5/20 | 0.33 |
| ▸ | LDHB | P07195 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8008687 | 0.90 | LDHA (0.41) | LDHAMGAT2LDHB | |
| SCHEMBL8010721 | 0.89 | LDHA (0.37) | LDHAMGAT2LDHB | |
| SCHEMBL7758845 | 0.86 | LDHA (0.48) | LDHALDHB | |
| SCHEMBL7999278 | 0.85 | LTA4H (0.39) | LDHAMGAT2 | |
| SCHEMBL8416462 | 0.84 | MGAT2 (0.35) | LDHAMGAT2 | |
| SCHEMBL8008735 | 0.82 | KCNA5 (0.37) | LDHA | |
| SCHEMBL8010411 | 0.81 | LDHA (0.40) | LDHAMGAT2LDHB | |
| SCHEMBL8010546 | 0.80 | LDHA (0.40) | LDHAMGAT2LDHB | |
| SCHEMBL8010782 | 0.77 | LDHA (0.38) | LDHALDHB | |
| SCHEMBL7998672 | 0.76 | PPARG (0.34) | MGAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6046355-A | TOLUENE-4-THIOSULFONIC ACID S-ESTERS AS CHEMICAL INTERMEDIATES FOR VIRICIDES AND ASPARTYL PROTEASE INHIBITORS; AIDS | WARNER-LAMBERT COMPANY (US) | 2000-04-04 | — | — | US | disclosed |
| EP-0935597-A2 | DIHYDROPYRONES WITH IMPROVED ANTIVIRAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998019997-A2 | DIHYDROPYRONES WITH IMPROVED ANTIVIRAL ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1998-05-14 | — | — | WO | disclosed |